D374Y-hPCSK9; Online Figure I ). For both vectors, expression of PCSK9 was driven by an efficient liver-specific promoter. Viral vectors in serotype 8 capsids (rAAV8-D377Y-mPCSK9 and rAAV8-D374Y-hPCSK9) were produced by the UNC Vector Core (Chapel Hill, NC). Female C57BL/6NTac mice were from Taconic, female Ldlr −/− mice (B6.129S7-Ldlr tm1Her /J) from Jackson Laboratories, and male Golden Syrian Hamsters from Harlan Laboratories. Breeding pairs of C57BL/6-Ins2 Akita /J and C57BL/6J mice were from Jackson Laboratories, and male offspring were used for experiments. The Danish Animal Experiments Inspectorate approved all experiments.
Experimental Design
Viral vectors were delivered via a single tail vein injection in mice and a single intraperitoneal injection in hamsters, and animals were Nonstandard Abbreviations and Acronyms LDL low-density lipoprotein
PCSK9
proprotein convertase subtilisin/kexin type 9 rAAV recombinant adeno-associated virus Figure 1 . Hypercholesterolemia induced by recombinant adeno-associated virus (rAAV) 8-D377Y-murine proprotein convertase subtilisin/kexin type 9 (mPCSK9). A, Mouse injected with rAAV8-CMV-Luc (left) or saline (right) and analyzed for bioluminescence. B, Plasma mPCSK9 in mice injected with the rAAV8-D377Y-mPCSK9 vector and fed Western-type diet (n=4 for all groups). ***P<0.0001 for doseresponse relationship among vector-injected groups (ANOVA for area under the curve with post-test for linear trend). C, Hepatic low-density lipoprotein receptor (LDLR) levels in different groups normalized to β-actin. Plasma total cholesterol on Paigen diet-(D) and Western-type dietfed (E) mice (n=4 for all groups, except for Ldlr −/− n=5). **P<0.01 and ***P<0.001 for dose-response relationship among vector-injected groups. challenged with either Western-type diet containing 21% fat and 0.21% cholesterol or cholate-supplemented Paigen diet containing 16% fat, 1.25% cholesterol, and 0.5% sodium cholate.
Aortic arch atherosclerotic lesion area (down to the supreme intercostal artery) was quantified en face after Oil Red O staining. Plaque morphology was examined in aortic root cross sections.
Results

Hypercholesterolemia Induced by PCSK9 Gene Transfer
Hydrodynamic injections of naked D377Y-mPCSK9-and D374Y-hPCSK9-encoding plasmids, a nonviral gene transfer approach, caused transient increase of plasma mPCSK9 and hPCSK9, respectively, in C57BL/6NTac mice (n=4 in each group; Online Figure IIA and IIB). This resulted in a temporally shifted phase of hypercholesterolemia (Online Figure IIC and IID) , which, however, was not maintained long enough to cause atherosclerosis.
Tissue tropism for AAV serotype 8 was visualized in C57BL/6NTac mice by bioluminescence using the luciferase reporter gene (rAAV8-CMV-Luc, 5.0×10
11 vector genomes). High levels of expression were seen in the upper abdomen consistent with efficient liver transduction ( Figure 1A ). rAAV8-CMV-Luc transduction did not increase plasma cholesterol levels, alanine aminotransferase activity, or serum amyloid A compared with saline-injected control mice (n=5 in each group; Online Figure IIIA-IIIC) .
To achieve long-term hypercholesterolemia, C57BL/6NTac mice, 8 weeks of age, were given rAAV8-D377Y-mPCSK9 or rAAV8-D374Y-hPCSK9 at 3 different dosages (2.0×10 10 , 1.0×10 11 , or 5.0×10 11 vector genomes) and fed either Western-type or Paigen diet. Ldlr −/− and saline-injected control mice were treated similarly. All mice thrived well (Online Table I ).
D377Y-mPCSK9 increased rapidly, peaking at day 56, and was stably maintained at high levels ( Figure 1B ). This resulted in strong reduction of hepatic LDL receptor levels ( Figure 1C ) and significant dose-dependent hypercholesterolemia on both diets ( Figure 1D and 1E) . As expected, cholesterol levels were higher on Paigen diet. Results with the rAAV8-D374Y-hPCSK9 vector were similar (Online Figure IV) .
Size-exclusion chromatography showed that low-dose rAAV8-D374Y-PCSK9 vector injection caused an isolated increase in LDL-sized lipoproteins on Western-type diet, whereas more very-low-density lipoprotein (VLDL)-sized lipoproteins were seen at higher D374Y-hPCSK9 levels and in Ldlr −/− mice (Online Figure V) . On Paigen diet, most plasma cholesterol was carried in VLDL-sized lipoproteins in all groups.
Plasma alanine aminotranferase activity and serum amyloid A were increased similarly in vector-injected and Ldlr −/− groups compared with controls (Online Figure VI) , indicating no hepatocellular injury or systemic inflammation caused by rAAV8 transduction alone.
Atherosclerosis Induced by PCSK9 Gene Transfer
Mice were euthanized 12 weeks after rAAV8 vector injection to quantify atherosclerosis ( Figure 2A ). Controls had no or minimal lesions on either diet, whereas all rAAV8-injected mice developed atherosclerosis in a dose-dependent manner ( Figure 2B ). Similar results were seen with the rAAV8-D374Y-hPCSK9 vector (Online Figure VII) .
Histological analysis of aortic root lesions showed advanced plaque development with foam cells, smooth muscle cells, and fibrous tissue ( Figure 2C-2F ). All, except 1 rAAV8-D377Y-mPCSK9-injected (high dose) and 1 Ldlr −/− mouse, exhibited necrotic core formation.
Applications of the Method
To show how the method can be used to examine the atherosclerosis susceptibility of a mouse strain without intercrossing with Apoe −/− or Ldlr −/− mice, we injected rAAV8-D377Y-mPCSK9
(1.0×10 11 vector genomes) in 26-week-old diabetic Akita mice with the Ins2 Akita mutation and analyzed atherosclerosis after 10 weeks on Western-type diet. Consistent with previous studies in the Ldlr −/− background, 10 we found augmented hypercholesterolemia and atherosclerosis compared with wild-type littermates (Figure 3 ). In this particular example, the effect of diabetes mellitus may have been underestimated because the level of plasma mPCSK9 was found to be lower in diabetic mice compared with controls (21 300 versus 56 000 ng/mL; n=4 both groups; P<0.03; Mann-Whitney). This will probably rarely be the case but serves to illustrate that analyzing for potential differences in the PCSK9 level obtained in groups is important when applying the atherosclerosis-inducing vector.
To provide an example of how the method can be used to create atherosclerosis models in nonmurine species, we injected Golden Syrian hamsters with a single intraperitoneal dose of the rAAV8-D374Y-hPCSK9 vector at 10 weeks of age (1.2×10 12 vector genomes). After 10 days, D374Y-hPCSK9 was efficiently expressed in plasma and the level stayed elevated (>2000 ng/mL) throughout the study (Online Figure VIII) . Marked hypercholesterolemia developed on Western-type diet ( Figure 4A ) with most cholesterol carried in VLDL-and LDL-sized lipoproteins ( Figure 4B ). After 12 weeks, all rAAV8-injected hamsters had scattered lesions in the aortic arch covering 3% to 6% of the surface area, whereas saline-injected controls showed no or minimal lesion development ( Figure 4C and 4D) . Histology of the aortic arch revealed foam cell lesions ( Figure 4E ). 
Discussion
Our experiments show that a single injection of PCSK9-encoding rAAV8 vectors is sufficient to induce atherosclerosis in mice and hamsters when combined with a cholate-free Western-type diet. This method should prove useful for high-throughput experiments or applications that involve genetic techniques, strains, or species that do not combine well with germline genetically engineered models. By circumventing the need for extensive breeding programs, it may also contribute to reducing the number of mice used for atherosclerosis research.
The efficiency of the technique stems from the noncell autonomous mechanism of action of PCSK9. PCSK9 is secreted into plasma and exerts its main function in the extracellular space. 11 As a result, ubiquitous reduction of hepatic LDL receptor levels can be achieved even if only a subgroup of hepatocytes is transduced with the rAAV8 vector.
The extent of atherosclerosis induced by the viral vectors was less than that of Ldlr −/− mice on Western-type diet, but more important for most research applications, lesions progressed to the fibroatheromatous stage and the coefficient of variation did not seem to be increased. If more extensive atherosclerosis is required, previous studies have shown that hepatic expression of rAAV8-encoded genes can be maintained far beyond the 12-week study period of the present study. 12 Because AAV vectors have broad species tropism and the PCSK9 and LDLR genes are conserved across mammals, 13 we hypothesized that the technique would not be constrained to the mouse, and we were able to induce hypercholesterolemia and early aortic atherosclerosis in Golden Syrian hamsters.
In conclusion, gain-of-function PCSK9-encoding rAAV8 vectors provide a versatile tool for experimental atherosclerosis research that overcomes some of the limitations of germline genetically engineered models and can be applied in mice and hamsters and potentially in other species.
